8-K//Current report
Nabriva Therapeutics plc 8-K
Accession 0001104659-23-083250
CIK 0001641640operating
Filed
Jul 23, 8:00 PM ET
Accepted
Jul 24, 9:00 AM ET
Size
199.8 KB
Accession
0001104659-23-083250
Documents
- 8-Ktm2321842d1_8k.htmPrimary
FORM 8-K
- EX-101.SCHnbrv-20230721.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABnbrv-20230721_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREnbrv-20230721_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLtm2321842d1_8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-23-083250-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001641640
Filing Metadata
- Form type
- 8-K
- Filed
- Jul 23, 8:00 PM ET
- Accepted
- Jul 24, 9:00 AM ET
- Size
- 199.8 KB